Effect of Ezetimibe on the Prevention and Dissolution of Cholesterol Gallstones

Gastroenterology

Volumn 134, Issue 7, 2008, Pages 2101-2110

  Wang, Helen H ^a   Portincasa, Piero ^b   Mendez Sanchez, Nahum ^c   Uribe, Misael ^c   Wang, David Q H ^a  

^a Division of Gastroenterology   (United States)

^b UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^c LIVER RESEARCH UNIT   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; EZETIMIBE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL MOUSE; CHOLESTEROL STONE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LIPID ABSORPTION; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 44849142781     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.03.011     Document Type: Article

References (37)

1. Wang D.Q.-H., and Afdhal N.H. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 6 (2004) 140-150
2. Portincasa P., Moschetta A., and Palasciano G. Cholesterol gallstone disease. Lancet 368 (2006) 230-239
3. Wang H.H., Afdhal N.H., and Wang D.Q.-H. Overexpression of estrogen receptor α increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res 47 (2006) 778-786
4. Turley S.D., and Dietschy J.M. The contribution of newly synthesized cholesterol to biliary cholesterol in the rat. J Biol Chem 256 (1981) 2438-2446
5. Wang D.Q.-H., Zhang L., and Wang H.H. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice. Biochim Biophys Acta 1733 (2005) 90-99
6. Diehl A.K. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 20 (1991) 1-19
7. Mendez-Sanchez N., Zamora-Valdes D., Chavez-Tapia N.C., et al. Role of diet in cholesterol gallstone formation. Clin Chim Acta 376 (2007) 1-8
8. Zhu X., Zhang S., and Huang Z. The trend of the gallstone disease in China over the past decade. Zhonghua Wai Ke Za Zhi 33 (1995) 652-658
9. Huang Y.C., Zhang X.W., and Yang R.X. Changes in cholelithiasis in Tianjin in the past 30 years. Chin Med J 97 (1984) 133-135
10. Huang Z.Q. Characteristic features of cholelithiasis in China. A nationwide survey of 11342 surgical cases 1983-1985. Zhonghua Wai Ke Za Zhi 25 (1987) 321-329
11. Nagase M., Tanimura H., Setoyama M., et al. Present features of gallstones in Japan. A collective review of 2,144 cases. Am J Surg 135 (1978) 788-790
12. Nakayama F., and Miyake H. Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition. Am J Surg 120 (1970) 794-799
13. Wang D.Q.-H., and Tazuma S. Effect of β-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res 43 (2002) 1960-1968
14. Zoli G., Ballinger A., Healy J., et al. Promotion of gallbladder emptying by intravenous amino acids. Lancet 341 (1993) 1240-1241
15. Carey M.C. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 19 (1978) 945-955
16. Wang D.Q.-H., and Carey M.C. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 37 (1996) 606-630
17. Wang D.Q.-H., Paigen B., and Carey M.C. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38 (1997) 1395-1411
18. Wang D.Q.-H., Lammert F., Paigen B., et al. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: pathophysiology of biliary lipid secretion. J Lipid Res 40 (1999) 2066-2079
19. Wang D.Q.-H., and Carey M.C. Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J Lipid Res 44 (2003) 1042-1059
20. Duan L.P., Wang H.H., and Wang D.Q.-H. Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. J Lipid Res 45 (2004) 1312-1323
21. Wang H.H., Afdhal N.H., Gendler S.J., et al. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology 131 (2006) 210-222
22. Wang D.Q.-H., Lammert F., Cohen D.E., et al. Cholic acid aids absorption, biliary secretion, and phase transitions of cholesterol in murine cholelithogenesis. Am J Physiol 276 (1999) G751-G760
23. Wang D.Q.-H., Tazuma S., Cohen D.E., et al. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am J Physiol 285 (2003) G494-G502
24. Buhman K.K., Accad M., Novak S., et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 6 (2000) 1341-1347
25. Wang H.H., and Wang D.Q.-H. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology 42 (2005) 894-904
26. Amigo L., Quinones V., Mardones P., et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet. Gastroenterology 118 (2000) 772-779
27. Davis Jr. H.R., Compton D.S., Hoos L., et al. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice. Arterioscler Thromb Vasc Biol 21 (2001) 2032-2038
28. Altmann S.W., Davis Jr. H.R., Zhu L.J., et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 303 (2004) 1201-1204
29. Portincasa P., Moschetta A., Colecchia A., et al. Measurements of gallbladder motor function by ultrasonography: towards standardization. Dig Liver Dis 35 Suppl 3 (2003) S56-S61
30. Portincasa P., Di Ciaula A., Wang H.H., et al. Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology 47 (2008) (in press)
31. Portincasa P., Di Ciaula A., and vanBerge-Henegouwen G.P. Smooth muscle function and dysfunction in gallbladder disease. Curr Gastroenterol Rep 6 (2004) 151-162
32. van Erpecum K.J., Wang D.Q.-H., Moschetta A., et al. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 47 (2006) 32-41
33. Mathur A., Walker J.J., Al-Azzawi H.H., et al. Ezetimibe ameliorates cholecystosteatosis. Surgery 142 (2007) 228-233
34. Tokyo Cooperative Gallstone Study Group. Efficacy and indications of ursodeoxycholic acid treatment for dissolving gallstones. A multicenter double-blind trial. Gastroenterology 78 (1980) 542-548
35. Sackmann M., Niller H., Klueppelberg U., et al. Gallstone recurrence after shock-wave therapy. Gastroenterology 106 (1994) 225-230
36. Temel R.E., Tang W., Ma Y., et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Invest 117 (2007) 1968-1978
37. Wang H.H., Portincasa P., and Wang D.Q.-H. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci 13 (2008) 401-423